Five things for pharma marketers to know: Wednesday, August 23, 2017

Doctors fret about price of Novartis' experimental CAR-T therapy; study finds digital pillboxes don't improve adherence; India awards Pfizer vaccine patent

Pharma's $6 billion annual ad spend targeted by media publishers

Condé Nast, Time Inc., and Vice Media have all recently launched health content businesses.

Horizon CEO Tim Walbert knows patients because he is one

Horizon CEO Tim Walbert knows patients because he is one

He was diagnosed years ago with a handful of autoimmune conditions, treating them with drugs like Abbvie's Humira, which he helped commercialize.

Diabetes drugs must prove their value to payers, analysts say

Diabetes drugs must prove their value to payers, analysts say

CVS Health's decision to remove Lilly's Jardiance for J&J's Invokana has analysts wondering if exclusive pricing contracts could shape the future of the GLP-1 class.

Investors put their money on point of care

Investors put their money on point of care

Two recent cash infusions suggest investors are bullish on point-of-care advertising. Is the channel ready for its moment in the spotlight?

Five things for pharma marketers to know: Tuesday, August 22, 2017

Five things for pharma marketers to know: Tuesday, August 22, 2017

Novartis launches MS study with Apple's ResearchKit; the FDA considering limiting risk info in drug ads; J&J loses baby powder lawsuit

Outcome Health hires former BMS exec Nancy Phelan

Outcome Health hires former BMS exec Nancy Phelan

She is leading commercial partnerships for the point-of-care company.

Five things for pharma marketers to know: Monday, August 21, 2017

Five things for pharma marketers to know: Monday, August 21, 2017

The FDA approves Ironwood's gout drug; GSW names new president; Samsung and Takeda to partner on biologic development

Always ad '#LikeAGirl' returns to fight girls' fear of failure

Always ad '#LikeAGirl' returns to fight girls' fear of failure

Procter & Gamble has revived the campaign with a new spot tackling the lack of confidence during puberty.

Sanofi adds WPP to creative roster in agency review

Sanofi adds WPP to creative roster in agency review

WPP was added to Sanofi's creative agency roster and GroupM's Mindshare is the drugmaker's new global media agency of record.

Five things for pharma marketers to know: Friday, August 18, 2017

Five things for pharma marketers to know: Friday, August 18, 2017

Lawmakers to investigate pricing of MS drugs; Mylan will pay $465 million to resolve EpiPen allegations; the FDA approves Pfizer's new cancer drug

Five things for pharma marketers to know: Thursday, August 17, 2017

Five things for pharma marketers to know: Thursday, August 17, 2017

Express Scripts to limit opioid coverage; Novo's diabetes drug lowers glucose levels in trial; startup aims to give doctors access to a patient's total costs

PhRMA criticizes the FDA's research into drug advertising and promotion

PhRMA criticizes the FDA's research into drug advertising and promotion

The lobbying group said it's unclear what the agency's goal is with this research and how it promotes public health.

Study: Hiking the prices of heart drugs led to fewer sales

Study: Hiking the prices of heart drugs led to fewer sales

Prescription rates dramatically decreased following the price hikes of Valeant's Isuprel and Nitropress in 47 hospitals.

Johnson & Johnson in breach of U.K. rules over Nicorette marketing

Johnson & Johnson in breach of U.K. rules over Nicorette marketing

Johnson & Johnson has breached the U.K.'s drug regulation code in three places in promotions for smoking cessation product Nicorette.

Five things for pharma marketers to know: Wednesday, August 16, 2017

Five things for pharma marketers to know: Wednesday, August 16, 2017

Gottlieb criticizes drugmakers for 'gaming the system' on generics; investors ignore Trump's pharma criticism; docs are more supportive of single payer

W2O's Sentient adds Spitz, Viola to leadership team

W2O's Sentient adds Spitz, Viola to leadership team

Both positions were newly created as the agency has grown over the past year.

Frazier's call earns him praise, rare for a pharma CEO

Frazier's call earns him praise, rare for a pharma CEO

It's not often that pharmaceutical companies are held up as examples of morality or leadership to the general public.

Five things for pharma marketers to know: Tuesday, August 15, 2017

Five things for pharma marketers to know: Tuesday, August 15, 2017

Pfizer accuses J&J of limiting biosimilar uptake; Trump again criticizes high drug prices; WebMD to reposition site to help consumers manage their health

Biogen, Merck use predictive modeling to better negotiate value-based contracts

Biogen, Merck use predictive modeling to better negotiate value-based contracts

What's holding back value-based pricing deals from moving beyond the pilot phase?